Key Details
Price
$227.88Last Dividend
$1.04Annual ROE
6.60%Beta
0.31Events Calendar
Next earnings date:
Feb 06, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
Nov 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Dec 09, 2024Next split:
N/ARecent split:
Apr 01, 2022Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.
Investors who focus on Medical - Dental Supplies stocks probably know about Becton Dickinson (BDX) and Merit Medical (MMSI). However, which of these companies is the better choice for those seeking undervalued stocks?
No matter if you focus on value, growth, or momentum investing, discovering solid stocks is simpler with the Zacks Style Scores, which is a key aspect of the Zacks Premium research service.
The blood testing method that combines BD's MiniDraw System with Babson's BetterWay technologies is expected to reduce typical obstacles to testing and enhance patient results.
The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons to make the most of this tool.
On December 17, 2024, BD (Becton, Dickinson and Company), a top global medical technology firm, and Babson Diagnostics, a healthcare technology company focused on science, revealed that they are expanding their fingertip blood collection and testing technologies. These advancements will be available for U.S. health systems and large provider networks, including urgent care centers and doctors' offices. This initiative aims to improve testing in various outpatient care environments.
On Monday, the U.S. Securities and Exchange Commission announced that it has reached a settlement with Becton Dickinson and Co. regarding claims that the company misled investors about the risks linked to its Alaris infusion pump.
On December 16, 2024, BD (Becton, Dickinson and Company), a major medical technology firm, announced that it has come to an agreement with the U.S. Securities and Exchange Commission (SEC). This agreement addresses an investigation concerning earlier public disclosures and SEC reporting about the BD Alaris™ System, which BD acquired from CareFusion in 2015. The Alaris System is part of BD's Medication Management Solutions division.
Matrix Asset Advisors, an asset management firm, has published its investor letter for the third quarter of 2023, which you can download here. The company expects economic growth to continue in 2025, although it predicts a small decrease from the 3% GDP seen in the last quarter. As of September 30, Matrix's Large Cap Value portfolio (LCV) showed a significant increase.
In this article, we will talk about four stocks from the Dental Supplies sector that could help investors make money. The stocks we will focus on are BDX, MCK, CAH, and MMSI.
FAQ
- What is the primary business of Becton Dickinson and?
- What is the ticker symbol for Becton Dickinson and?
- Does Becton Dickinson and pay dividends?
- What sector is Becton Dickinson and in?
- What industry is Becton Dickinson and in?
- What country is Becton Dickinson and based in?
- When did Becton Dickinson and go public?
- Is Becton Dickinson and in the S&P 500?
- Is Becton Dickinson and in the NASDAQ 100?
- Is Becton Dickinson and in the Dow Jones?
- When was Becton Dickinson and's last earnings report?
- When does Becton Dickinson and report earnings?
- Should I buy Becton Dickinson and stock now?